← Back to Clinical Trials
Recruiting NCT07511465

NCT07511465 Development, Sensory Profile, and Sleep Quality in Preschool Children Across Different Caregiving Models

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07511465
Status Recruiting
Phase
Sponsor Fenerbahce University
Condition Child Development
Study Type OBSERVATIONAL
Enrollment 135 participants
Start Date 2026-01-05
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 6 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 135 participants in total. It began in 2026-01-05 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to examine developmental status, sensory processing, and sleep quality in preschool children aged 3 to 6 years across different caregiving models. Children raised primarily by first-degree relatives, second-degree relatives, caregivers, or in daycare settings will be compared. Data will be collected using the Denver II Developmental Screening Test, the Dunn Sensory Profile, and the Tayside Children's Sleep Questionnaire. The study will also evaluate the relationships among developmental status, sensory processing, and sleep quality, and explore whether caregiving model is associated with differences in these outcomes.

Eligibility Criteria

Inclusion Criteria: * Preschool children aged 3 to 6 years * Child has been raised within the same primary caregiving model for at least the past 6 months * Parent or legal guardian is willing to participate voluntarily and provide informed consent * Child and caregiver are able to understand Turkish and follow the study instructions Exclusion Criteria: * Previously diagnosed neurological, developmental, or psychiatric disorder (e.g., autism spectrum disorder, attention-deficit/hyperactivity disorder, developmental delay) * Currently receiving treatment or therapy for sensory processing problems, sleep problems, or developmental difficulties * Parent or legal guardian provides incomplete or incorrect study forms * Child is unable to cooperate with or complete the assessment procedures

Contact & Investigator

Central Contact

Sümeyye Akçay, Asst. Prof.

✉ smyye.akcy@gmail.com

📞 +905424002553

Principal Investigator

Sümeyye Akçay

PRINCIPAL INVESTIGATOR

Fenerbahçe University

Frequently Asked Questions

Who can join the NCT07511465 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Child Development. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07511465 currently recruiting?

Yes, NCT07511465 is actively recruiting participants. Contact the research team at smyye.akcy@gmail.com for enrollment information.

Where is the NCT07511465 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07511465 clinical trial?

NCT07511465 is sponsored by Fenerbahce University. The principal investigator is Sümeyye Akçay at Fenerbahçe University. The trial plans to enroll 135 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology